Get trade alerts

Unicycive Therapeutics ($UNCY) Insider Trading & Smart Money Activity

Unicycive Therapeutics, Inc. · Biotechnology · Latest filing Jul 1, 2026

Unicycive Therapeutics, Inc. ($UNCY) has 6 analyst ratings on file.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
6

UNCY insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All UNCY insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst Noble Capital Markets Reiterates to buy PT $50 +2.8%-5.1% Read
Analyst Benchmark Reiterates to buy PT $13 +2.8%-5.1% Read
Analyst HC Wainwright Reiterates to buy PT $15 +15.8%+13.0% Read
Analyst HC Wainwright Reiterates to buy PT $15 +15.8%+13.0% Read
Analyst B. Riley Securities Reiterates to buy PT $22 +15.8%+13.0% Read
Analyst B. Riley Securities Reiterates to buy PT $22 +15.8%+13.0% Read

1W / 1M / 6M = how UNCY moved from the trade or filing date.

Analyst ratings on UNCY

DateFirmActionRatingPrice target1W1M6MStory
Noble Capital Markets Reiterates buy $50 +2.8%-5.1% Read
Benchmark Reiterates buy $13 +2.8%-5.1% Read
HC Wainwright Reiterates buy $15 +15.8%+13.0% Read
HC Wainwright Reiterates buy $15 +15.8%+13.0% Read
B. Riley Securities Reiterates buy $22 +15.8%+13.0% Read
B. Riley Securities Reiterates buy $22 +15.8%+13.0% Read

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text